Skip to content
Menu

Indaptus Therapeutics, Inc. INDP

Full chart Compare
Set alert

Price alert · INDP

All alert types
3.13 USD -0.16 (-4.86%)

Regular-session close

3.13 0.00 0.00%

After hours · Nov 19, 4:00 PM ET

3.10 Day range 3.31
0.92 52-week range 5.96
YTD
+7.56%
1 year
+51.21%

Analyst view

Price target (mean) 8.50 +171.6% upside
Target (low)
5.00
Target (mean)
8.50
Target (high)
12.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy0
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 2
  • 1 month ago 2

Included in Essentials and up

Sign in to see Revenue and earnings forecast

Reported revenue and earnings per share by year, then what analysts expect next.

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

INDP analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.41-0.41 – -0.41-0.47+12.8%00.0%1
Next quarter-0.41-0.41 – -0.41-0.45+8.9%00.0%1
Current year-1.79-1.79 – -1.79-1.83+2.2%00.0%1
Next year-1.38-1.38 – -1.38-1.79+22.9%00.0%1

Upgrades and downgrades

The latest rating changes

INDP analyst upgrades and downgrades
DateFirmActionFromTo
Nov 13, 2024Maxim GroupMaintainedBuyBuy
Oct 16, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 17, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 20, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 15, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 11, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 8, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 4, 2023HC Wainwright & Co.Reiterated—Buy
Mar 20, 2023HC Wainwright & Co.Maintained—Buy
Mar 8, 2023HC Wainwright & Co.Reiterated—Overweight
Feb 8, 2023HC Wainwright & Co.Reiterated—Buy
Oct 19, 2021Maxim GroupUpgradeHoldBuy

Included in Plus and up

Sign in to see Analyst trend

Two years of the analyst rating mix and the average price target against the price.